Quiapeg Pharmaceuticals Ab

Other

Quiatech Ab

Wallac Oy

Quiapeg Ab

Pharmacia Ab

Helicos Biosciences Corporation

Marek Kwiatkowski

Ulf Landegren

Mats Nilsson

Christian Sund

Veli-Matti Mukkala

Ilkka Hemmila

Jan P Carlsson

Timo Lovgren

Sven O Oscarsson

Hakan Drevin

Anna T Martin

Jyrki Ylikoski

The present application provides compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein D is a residue of a GLP-polypeptide or an analog thereof, which underdo hydrolysis under physiological conditions to release the GLP-polypeptide or analog thereof and which are useful in the treatment of disorders that could be beneficially treated with the GLP-polypeptide or analog thereof.

Releasable GLP-1 conjugates

The present application provides compounds of Formula (B): or pharmaceutically acceptable salts thereof, wherein D is a residue of a biologically active drug, which underdo hydrolysis under physiological conditions to release the biologically active drug and which are useful in the treatment of disorders that could be beneficially treated with the drug.

Releasable conjugates

This document relates to functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene glycol and related polymers) as well as methods and materials for making and using such functionalized polymers.

Functionalized polymers

This document relates to conjugates of TNF inhibitors or derivatives thereof and functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene glycol and related polymers) as well as methods and materials for making and using such conjugates.

Conjugates of tumor necrosis factor inhibitors to functionalized polymers

This document relates to conjugates of a biologically active molecule or a derivative thereof and functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene glycol and related polymers) as well as methods and materials for making and using such conjugates.

Conjugates of biologically active molecules to functionalized polymers

Growing community of inventors

Uppsala, Sweden

Marek Kwiatkowski